Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: Data from the French REAL.FR cohort

Journal of Nutrition, Health and Aging

Volumn 9, Issue 2, 2005, Pages 69-73

  Gillette Guyonnet, S ^a,b,c   Cortes, F ^a,b   Cantet, C ^b   Vellas, B ^a,b  

^a CHU PURPAN   (France)

^b INSERM   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Observational study; Weight loss

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; PLACEBO; PSYCHOTROPIC AGENT; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COHORT ANALYSIS; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SIDE EFFECT; WEIGHT REDUCTION;

EID: 16444370821     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, von Strauss E, Winblad B. Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health 1998; 88: 1452-1456.
2. Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer Disease. Ann Intern Med 2004; 140: 501-509.
3. White H, Pieper C, Schmader K, Fillenbaum O. Weight change in Alzheimer's disease. J Am Geriatr Soc 1996; 44: 265-272.
4. Gillette-Ouyonnet S, Nourhashemi F, Andrieu S, et al. Weight loss in Alzheimer's disease. Am J Clin Nutr 2000; 71 (Suppl.): 637S-642S.
5. Schneider LS. The future of cholinergic replacement therapy in Alzheimer's Disease. Current Opinion in CPNS Investigational Drugs 2000; 2, 4: 427-437.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV). Washington, DC: APA, 1997.
7. McKhann O, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
8. Agence National d'Accréditation et d'Evaluation en Santé. Recommandations pratiques pour le diagnostic de la maladie d'Alzheimer. St-Denis La Plaine, France: ANAES, February 2000.
9. Katz S, Ford AB, Moskowitz RW, et al. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-919.
10. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-186.
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
12. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's Disease. Am J Psychiatry 1984; 141: 1356-1364
13. Reisberg B, Ferns SH, de Leon J, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-1139.
14. Hughes CP, Berg L, Danziger WI, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
15. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
16. Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999; 15: 116-122.
17. Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980; 20: 649-655.
18. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 1995; 43: 329-337.
19. Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72: 310-314.
20. Guyonnet S, Nourhashemi F, Andrieu S, et al. A prospective study of changes in nutritional status in Alzheimer's patients. Arch Gerontol Geriatr 1998; Suppl.6: 255-262.